Who we are

Octapharma is one of the largest human protein manufacturers in the world.

About Octapharma

Family-owned since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 120 countries and reach hundreds of thousands of patients every year. We focus on three therapeutic areas: haematology, immunotherapy and critical care.

Octapharma is one of the largest human protein product manufacturers. We develop and produce medicines based on human proteins from human cell lines and human plasma, sourced from our own plasma donation centres and other external sources.

Octapharma at a glance

employees

state-of-the-art manufacturing sites

preclinical and clinical R&D sites

+

plasma donation centres

€ bn

revenue

Our culture

Our vision

Our passion drives us to provide new health solutions advancing human life. This vision serves as our navigational reference point.
Our strategy

Shaping the future of Octapharma

Continue to ensure the safe and optimal use of human proteins and expand the portfolio to deliver innovative health solutions advancing human life.

Efficiency

Prioritise IG yield improvements and optimise plasma collection / production capacities to support future growth and increase revenues per litre.

Innovation

Strengthen our commitment to haematology, immunology and critical care by enhancing and expanding our portfolio into adjacent areas and new indications.

Accessibility

Expand accessibility of our therapies to more patients around the world.

Responsibility

Reaffirm Octapharma’s family ownership, long-term vision and commitment to patients and responsible value creation.

Engagement

Remain an employer of choice.

Advancing Human Life. Together.

Our Annual Report provides a comprehensive overview of who we are and what we do.